Viewing Study NCT00429793


Ignite Creation Date: 2025-12-25 @ 1:20 AM
Ignite Modification Date: 2025-12-25 @ 11:28 PM
Study NCT ID: NCT00429793
Status: COMPLETED
Last Update Posted: 2019-07-24
First Post: 2007-01-30
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Temsirolimus in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
Sponsor: National Cancer Institute (NCI)
Organization: